Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent advances in PPARs research--basic and clinical aspects].

Takashi Kadowaki1

  • 1Department of Metabolic Diseases, Graduate School of Medicine and Faculty of Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency.

Biochimica et biophysica acta·2015
Same author

Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.

Medicine·2015
Same author

A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

The Journal of biological chemistry·2015
Same author

Brachial-ankle pulse wave velocity is associated with coronary calcification among 1131 healthy middle-aged men.

International journal of cardiology·2015
Same author

DialBetics With a Multimedia Food Recording Tool, FoodLog: Smartphone-Based Self-Management for Type 2 Diabetes.

Journal of diabetes science and technology·2015
Same author

Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.

Expert opinion on pharmacotherapy·2015
See all related articles

Peroxisome proliferator-activated receptors (PPARs) regulate metabolism and energy. Recent research clarifies their roles in conditions like diabetes and atherosclerosis, guiding new drug development.

Area of Science:

  • Molecular biology
  • Metabolic research
  • Pharmacology

Context:

  • Peroxisome proliferator-activated receptors (PPARs), including PPARalpha, beta/delta, and gamma, are key regulators of metabolic processes.
  • These nuclear receptors influence glucose and lipid metabolism, energy balance, and the development of atherosclerosis.
  • Understanding the distinct and overlapping functions of PPAR subtypes is crucial for metabolic disease research.

Purpose:

  • To review recent advancements in PPARs research, covering both fundamental science and clinical applications.
  • To highlight the elucidation of specific and common actions of PPAR subtypes using various research models.
  • To provide an overview of current drug development efforts targeting PPARs for metabolic disorders.

Summary:

Related Experiment Videos

  • PPARs (PPARalpha, beta/delta, gamma) are vital for regulating glucose, lipid metabolism, energy homeostasis, and atherosclerosis.
  • Studies using mouse models and specific agonists have clarified the unique and shared functions of these receptors.
  • This review synthesitsizes recent findings on PPARs from basic science and clinical studies, informing therapeutic strategies.

    • Impact:

    • Advances in PPARs research are paving the way for novel therapeutic agents.
    • Targeting PPARs offers potential treatments for metabolic disorders like diabetes and hyperlipidemia.
    • Understanding PPARs contributes to developing strategies for managing atherosclerosis and related cardiovascular diseases.